[1]
Teixeira HM. Recent Advances and Future Developments in Forensic Toxicology. Anal Bioanal Chem 2014; 406(15): 3551-2.
[2]
Xingxing D, Marilyn AH. New Synthetic Cannabinoids Metabolism and Strategies to Best Identify Optimal Marker Metabolites. Front Chem 2019; 7: 109.
[3]
Fu S, Stove C, Elliott S. Editorial: Advances in Analytical Methods for Drugs of Abuse Testing. Front Chem 2019; 7: 589.
[4]
Pantano F, Graziano S, Pacifici R, Busardò FP, Pichini S. New Psychoactive Substances: A Matter of Time. Curr Neuropharmacol 2019; 17(9): 818-22.
[5]
Zaami S. New Psychoactive Substances: Concerted Efforts and Common Legislative Answers for Stemming a Growing Health Hazard. Eur Rev Med Pharmacol Sci 2019; 23(22): 9681-90.
[6]
Lo Faro AF, Di Trana A, La Maida N, Tagliabracci A, Giorgetti R, Busardò FP. Biomedical analysis of New Psychoactive Substances (NPS) of natural origin. J Pharm Biomed Anal 2020; 170, 112945
[7]
Early warning system on NPS. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Available at: www.emcdda.europa.eu/publications/topic-overviews/eu-early-warning-system_en
[8]
Marchei E, Pacifici R, Mannocchi G, Marinelli E, Busardò FP, Pichini S. New synthetic opioids in biological and non-biological matrices: A review of current analytical methods. Trends Analyt Chem 2018; 102: 1-15.